ALBERTDAVD850.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹485 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt2.110.028.528.5
Net Debt-257.6-232.6-196.9-196.9
Total Debt/Equity0.010.030.070.07
Net Debt/Equity-0.67-0.59-0.50-0.50
Total Debt/EBITDA0.043.325.215.21
Net Debt/EBITDA-5.50-76.85-36.01-7.36
Interest Coverage (EBIT/Interest)124.70-9.61-1.63-1.63
Total Debt/Total Capital %0.552.506.786.78
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.